Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Nicholas V. Cozzi"'
Autor:
Robert B. Kargbo, Alexander Sherwood, Andrew Walker, Nicholas V. Cozzi, Raymond E. Dagger, Jessica Sable, Kelsey O’Hern, Kristi Kaylo, Tura Patterson, Gary Tarpley, Poncho Meisenheimer
Publikováno v:
ACS Omega, Vol 5, Iss 27, Pp 16959-16966 (2020)
Externí odkaz:
https://doaj.org/article/48d2c06570584f16b165e38b99e1fef2
Autor:
Nicholas V. Cozzi, Kevin F. Foley
Publikováno v:
BioTechniques, Vol 32, Iss 3, Pp 486-492 (2002)
Externí odkaz:
https://doaj.org/article/a8dbcaa0ca6f44808b03d4cbb6e5d460
Autor:
Emmanuelle A. D. Schindler, R. Andrew Sewell, Christopher H. Gottschalk, Christina Luddy, L. Taylor Flynn, Yutong Zhu, Hayley Lindsey, Brian P. Pittman, Nicholas V. Cozzi, Deepak C. D'Souza
Publikováno v:
Headache: The Journal of Head and Face Pain. 62:1383-1394
Using a patient-informed regimen, we conducted an exploratory randomized, double-blind, placebo-controlled study to systematically investigate the effects of psilocybin in cluster headache.Sustained reductions in cluster headache burden after limited
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ff59f9b6dafdf31bbf6520e6605f639
https://doi.org/10.1111/head.14420
https://doi.org/10.1111/head.14420
Autor:
Deepak Cyril D’Souza, Shariful A. Syed, L. Taylor Flynn, Hamideh Safi-Aghdam, Nicholas V. Cozzi, Mohini Ranganathan
Publikováno v:
Neuropsychopharmacology. 47:1854-1862
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d21b9190aef365644734f0e30efd271b
https://doi.org/10.1038/s41386-022-01344-y
https://doi.org/10.1038/s41386-022-01344-y
Autor:
Tura Patterson, Andrew Walker, Poncho Meisenheimer, Robert B. Kargbo, Raymond E. Dagger, Jessica Sable, Kristi W. Kaylo, Alexander M. Sherwood, Kelsey O’Hern, Nicholas V. Cozzi, Gary Tarpley
Publikováno v:
ACS Omega, Vol 5, Iss 27, Pp 16959-16966 (2020)
ACS Omega
ACS Omega
A second-generation kilogram-scale synthesis of the psychedelic tryptamine psilocybin has been developed. The synthesis was designed to address several challenges first encountered with the scale-up of previously described literature procedures, whic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::663479ee822815218ef4ade53fad7f10
https://doi.org/10.1021/acsomega.0c02387
https://doi.org/10.1021/acsomega.0c02387
Autor:
Alexander M. Sherwood, Robert B. Kargbo, Kristi W. Kaylo, Nicholas V. Cozzi, Poncho Meisenheimer, James A. Kaduk
Publikováno v:
Acta crystallographica. Section C, Structural chemistry. 78(Pt 1)
Psilocybin {systematic name: 3-[2-(dimethylamino)ethyl]-1H-indol-4-yl dihydrogen phosphate} is a zwitterionic tryptamine natural product found in numerous species of fungi known for their psychoactive properties. Following its structural elucidation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbb749990a0120f00ea6e924450343fa
https://pubmed.ncbi.nlm.nih.gov/35119383
https://pubmed.ncbi.nlm.nih.gov/35119383
Autor:
R. Andrew Sewell, Deepak Cyril D'Souza, Nicholas V. Cozzi, L Taylor Flynn, Emmanuelle A. D. Schindler, Christina Luddy, Christopher Gottschalk, Hayley Lindsey, Brian Pittman
Publikováno v:
Neurotherapeutics
While anecdotal evidence suggests that select 5-hydroxytryptamine 2A (5-HT(2A)) receptor ligands, including psilocybin, may have long-lasting therapeutic effects after limited dosing in headache disorders, controlled investigations are lacking. In an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1ff7ff0abf95164dcee8aa037263222
https://pubmed.ncbi.nlm.nih.gov/33184743
https://pubmed.ncbi.nlm.nih.gov/33184743
Publikováno v:
Neuropharmacology. 142:231-239
Substantial effort has been devoted toward understanding the psychopharmacological effects of tryptamine hallucinogens, which are thought to be mediated by activation of 5-HT(2A) and 5-HT(1A) receptors. Recently, several psychoactive tryptamines base
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::677e16355f8ae7c4cdb72ef892029e89
https://doi.org/10.1016/j.neuropharm.2018.02.028
https://doi.org/10.1016/j.neuropharm.2018.02.028
Autor:
Christopher R. Nicholas, Nicholas V. Cozzi, Randall Brown, Michele Gassman, Chantelle Thomas, Paul R. Hutson, Karen M. Cooper, Scott Hetzel, Daniel Muller, Kelsey M. Henriquez
Publikováno v:
J Psychopharmacol
Aim: The aim of the current study was to investigate the relationship between escalating higher doses of psilocybin and the potential psilocybin occasioned positive subjective effects. Methods: Healthy participants ( n=12) were given three escalating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::194c6b45e3aeae1e6551f6d21242a2f3
https://doi.org/10.1177/0269881118780713
https://doi.org/10.1177/0269881118780713
Autor:
Róbert Berkecz, Ákos Menyhárt, Ferenc Bari, Viktória Varga, István A. Krizbai, Írisz Szabó, Ede Frecska, Szabolcs Dvorácskó, Eszter Farkas, Tímea Körmöczi, Nicholas V. Cozzi, Szilvia Kecskés, Rita Frank, Csaba Tömböly, Attila Farkas, Dóra Hantosi
Publikováno v:
Neuropharmacology. 192:108612
Dimethyltryptamine (DMT), an endogenous ligand of sigma-1 receptors (Sig-1Rs), acts against systemic hypoxia, but whether DMT may prevent cerebral ischemic injury is unexplored. Here global forebrain ischemia was created in anesthetized rats and aggr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6e8ff9c265d69e10de574fe714b60e4
https://doi.org/10.1016/j.neuropharm.2021.108612
https://doi.org/10.1016/j.neuropharm.2021.108612